These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7747716)

  • 1. Interim results on a randomized trial of mitomycin C in combination with orchidectomy for newly diagnosed metastatic prostate cancer.
    Vandenbroucke F; Van Poppel H; Derluyn J; Popelier G; Casselman J; Billiet I; Vanuytsel L; Paridaens R; Baert L
    Am J Clin Oncol; 1995 Jun; 18(3):263-6. PubMed ID: 7747716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin C in combination with orchiectomy for newly diagnosed metastatic prostate cancer: preliminary results on a randomized trial.
    Van Poppel H; van den Broucke F; Derluyn J; Popelier G; Casselman J; Billiet I; van Uytsel L; Paridaens R; Baert L
    J Urol; 1993 Jun; 149(6):1485-7. PubMed ID: 8501794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin C for metastatic prostate cancer: final analysis of a randomized trial.
    Boel K; Van Poppel H; Goethuys H; Derluyn J; Vandenbroucke F; Popelier G; Casselman J; Billiet I; Vanuytsel L; Paridaens R; Baert L
    Anticancer Res; 1999; 19(3B):2157-61. PubMed ID: 10472324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893.
    Fosså SD; Curran D; Aaronson NK; Keuppens F; Kliment J; Robinson MR; DeReijke TM; Hetherington J; Kil PJ; Rea LA
    Eur Urol; 2000 May; 37(5):541-51. PubMed ID: 10765092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orchiectomy and orchiectomy plus mitomycin C for metastatic prostate cancer in patients with poor prognosis: the final results of a European Organization for Research in Cancer Therapy Genitourinary Group Trial.
    de Reijke TM; Keuppens FI; Whelan P; Kliment J; Robinson MR; Rea LA; Sylvester RJ
    J Urol; 1999 Nov; 162(5):1658-64; discussion 1664-5. PubMed ID: 10524892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U.K. trials of treatment for M1 prostatic cancer. The LH-RH analogue Zoladex vs. orchidectomy.
    Ryan PG; Peeling WB
    Am J Clin Oncol; 1988; 11 Suppl 2():S169-72. PubMed ID: 2977272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
    Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
    Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer.
    Ansari MS; Gupta NP
    BJU Int; 2003 Sep; 92(4):375-8; discussion 378. PubMed ID: 12930422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
    Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
    Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of goserelin acetate versus mitomycin C plus goserelin acetate in previously untreated prostate cancer patients with bone metastases.
    Fontana D; Bertetto O; Fasolis G; Berruti A; Tarabuzzi R; Pagani G; Buniva T; Zolfanelli R; Pallotti S; Frezzotti L; Bumma C; Rossetti SR; Dogliotti L
    Tumori; 1998; 84(1):39-44. PubMed ID: 9619712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral orchidectomy and flutamide versus orchidectomy alone in newly diagnosed patients with metastatic carcinoma of the prostate--an Australian multicentre trial.
    Zalcberg JR; Raghaven D; Marshall V; Thompson PJ
    Br J Urol; 1996 Jun; 77(6):865-9. PubMed ID: 8705223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total androgen blockade for metastatic cancer of the prostate.
    Béland G; Elhilali M; Fradet Y; Laroche B; Ramsey EW; Trachtenberg J; Venner PM
    Am J Clin Oncol; 1988; 11 Suppl 2():S187-90. PubMed ID: 3149456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.
    Pili R; Häggman M; Stadler WM; Gingrich JR; Assikis VJ; Björk A; Nordle O; Forsberg G; Carducci MA; Armstrong AJ
    J Clin Oncol; 2011 Oct; 29(30):4022-8. PubMed ID: 21931019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer.
    Qin XJ; Ma CG; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu Y; Zhu YP; Shi GH; Xiao WJ; Lin GW; Swanson GP
    Urol Oncol; 2012; 30(2):145-9. PubMed ID: 20451424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up.
    Oh WK; Manola J; Bittmann L; Brufsky A; Kaplan ID; Smith MR; Kaufman DS; Kantoff PW
    Urology; 2003 Jul; 62(1):99-104. PubMed ID: 12837431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term versus long-term addition of cyproterone acetate to buserelin therapy in comparison with orchidectomy in the treatment of metastatic prostate cancer. European Organization for Research and Treatment of Cancer--Genitourinary Group.
    Klijn JG; de Voogt HJ; Studer UE; Schröder FH; Sylvester R; De Pauw M
    Cancer; 1993 Dec; 72(12 Suppl):3858-62. PubMed ID: 8252504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orchidectomy prior to definitive radiotherapy for localized prostatic cancer.
    Spry NA; Meffan PM; Christie DR; Morum PE
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1045-53. PubMed ID: 8600087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
    Tucci M; Bertaglia V; Vignani F; Buttigliero C; Fiori C; Porpiglia F; Scagliotti GV; Di Maio M
    Eur Urol; 2016 Apr; 69(4):563-573. PubMed ID: 26422676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renaissance of estrogen therapy in advanced prostate carcinoma?].
    Smith PH; Robinson MR
    Urologe A; 1995 Sep; 34(5):393-7. PubMed ID: 7483156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy of prostatic bone metastases.
    Huben RP
    Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.